PIANTONI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 1.576
EU - Europa 1.016
AS - Asia 599
SA - Sud America 108
AF - Africa 11
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.316
Nazione #
US - Stati Uniti d'America 1.566
DE - Germania 211
SG - Singapore 202
IT - Italia 185
CN - Cina 167
HK - Hong Kong 133
PL - Polonia 132
FI - Finlandia 118
BR - Brasile 100
UA - Ucraina 93
GB - Regno Unito 65
RU - Federazione Russa 58
FR - Francia 35
TR - Turchia 33
IE - Irlanda 29
SE - Svezia 27
NL - Olanda 14
VN - Vietnam 10
AT - Austria 9
IN - India 9
BD - Bangladesh 8
MK - Macedonia 7
BE - Belgio 6
CA - Canada 6
GR - Grecia 6
CZ - Repubblica Ceca 5
AR - Argentina 4
EG - Egitto 4
ID - Indonesia 4
PT - Portogallo 4
ZA - Sudafrica 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
ES - Italia 3
IQ - Iraq 3
JP - Giappone 3
KR - Corea 3
PH - Filippine 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
EU - Europa 2
IL - Israele 2
JO - Giordania 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
GE - Georgia 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
UG - Uganda 1
Totale 3.316
Città #
Fairfield 222
Ashburn 175
Singapore 144
Hong Kong 131
Warsaw 130
Woodbridge 118
Chandler 91
Seattle 88
Cambridge 84
Houston 84
Helsinki 79
Jacksonville 79
Wilmington 76
New York 64
Munich 61
Beijing 59
Princeton 58
Ann Arbor 44
Brescia 32
Turku 32
Dublin 29
Istanbul 29
Los Angeles 18
Milan 16
Moscow 16
Des Moines 15
San Francisco 14
San Diego 13
Bergamo 12
Shanghai 12
Nanjing 11
The Dalles 11
London 10
São Paulo 10
Changsha 8
Dallas 8
Nanchang 8
Nuremberg 8
Salò 8
Vienna 7
Brussels 6
Ferrara 6
Shenyang 6
Frankfurt am Main 5
Haikou 5
Hanoi 5
Jiaxing 5
Ningbo 5
Nürnberg 5
Santa Clara 5
Bosio 4
Cairo 4
Chicago 4
Dhaka 4
Dong Ket 4
Dosso 4
Hebei 4
Jakarta 4
Lappeenranta 4
Olomouc 4
Redwood City 4
Rivoli 4
Rome 4
State College 4
Amsterdam 3
Baku 3
Belo Horizonte 3
Boardman 3
Brooklyn 3
Columbus 3
Duncan 3
Falkenstein 3
Guangzhou 3
Jinan 3
Johannesburg 3
Mariano Comense 3
New Bedfont 3
Norwalk 3
Pescara 3
Romola 3
Skopje 3
Sommacampagna 3
Stockholm 3
Tianjin 3
Vancouver 3
Varallo Pombia 3
Verona 3
Abu Dhabi 2
Amman 2
Astana 2
Atlanta 2
Bagheria 2
Basra 2
Birmingham 2
Buffalo 2
Calolziocorte 2
Chennai 2
Chongqing 2
Cosenza 2
Danville 2
Totale 2.318
Nome #
9A.07: CARDIOVASCULAR TARGET ORGAN DAMAGE IN PREMENOPAUSAL SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS AND IN CONTROLS. ARE THERE ANY DIFFERENCES? 286
Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes 152
Prevalence and disease-specific risk factors for Lower Urinary Tract symptoms in Systemic Sclerosis: an international multi-centric study 150
Decreased circulating t regulatory lymphocytes in obese patients undergoing bariatric surgery 145
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case–control study 139
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 136
The limited cutaneous form of systemic sclerosis is associated with urinary incontinence: an international multicentre study 134
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab 132
Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. 129
Cardiovascular target organ damage in premenopausal systemic lupus erythematosus patients and in controls: Are there any differences? 126
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 122
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 112
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al 112
Pathophysiological role and therapeutic implications of vitamin d in autoimmunity: Focus on chronic autoimmune diseases 104
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 103
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 103
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome 101
Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept 99
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 83
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 82
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system 77
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy. 70
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic Sclerosis 66
CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept 56
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al 53
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome. 52
The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus 51
Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies 51
Bridging the Diagnostic Gap for Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders: Evidence of a Common Extracellular Matrix Fragmentation Pattern in Patient Plasma as a Potential Biomarker 44
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada 43
Calprotectin as a biomarker in rheumatoid arthritis: the potential predictive value of response to treatment 41
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases 41
Multiparametric autoantibody analysis: a new paradigm for the diagnosis of connective tissue diseases 36
Pregnancy in antiphospholipid syndrome: what should a rheumatologist know? 35
Regulation of neutrophil associated RNASET2 expression in rheumatoid arthritis 35
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 26
Editorial: Into the heart of systemic autoimmune diseases. 26
Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center 23
Urinary incontinence in systemic sclerosis: a prospective multicentre cohort study 20
Totale 3.396
Categoria #
all - tutte 20.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 7 48 48 148 32 57 30 44 45 73 36 34
2021/2022321 26 24 9 29 3 26 14 17 15 51 44 63
2022/2023250 33 8 7 19 27 62 3 28 46 0 7 10
2023/2024419 23 11 57 44 22 82 12 63 60 6 2 37
2024/2025933 9 19 21 110 71 83 57 54 96 94 181 138
2025/202667 67 0 0 0 0 0 0 0 0 0 0 0
Totale 3.396